Arthur He
Stock Analyst at HC Wainwright & Co.
(0)
# 4943
Out of 5,240 analysts
70
Total ratings
17.78%
Success rate
-32.93%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Solid Biosciences | Reiterates: Buy | 16 16 | 3.14 | 409.55% | 8 | Jan 13, 2025 | |
Nektar Therapeutics | Reiterates: Buy | 7 7 | 0.92 | 606.52% | 1 | Jan 13, 2025 | |
HOOKIPA Pharma | Downgrades: Neutral | n/a | n/a | n/a | 7 | Jan 10, 2025 | |
LAVA Therapeutics | Maintains: Buy | 6 2 | 0.98 | 104.08% | 8 | Dec 20, 2024 | |
Poseida Therapeutics | Downgrades: Neutral | 20 9 | n/a | n/a | 17 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 4 | 0.56 | 525% | 5 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 2.78 | 259.71% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 1.8 | 177.78% | 8 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 39 | n/a | n/a | 4 | May 28, 2024 |